# The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

> **NCT06281353** · PHASE2,PHASE3 · COMPLETED · sponsor: **Indonesia University** · enrollment: 78 (actual)

## Conditions studied

- Anogenital Wart

## Interventions

- **DRUG:** Curcumin Oral Capsule
- **DRUG:** Trichloroacetic acid
- **PROCEDURE:** Blood sample collection
- **PROCEDURE:** Cotton swab

## Key facts

- **NCT ID:** NCT06281353
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-16
- **Primary completion:** 2023-09-06
- **Final completion:** 2023-09-06
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281353, "The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06281353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*